Cite

HARVARD Citation

    da Silva, A. et al. (n.d.). Target-directed development and preclinical characterization of the proposed biosimilar rituximab GP2013. Leukemia & lymphoma. 55 (7), pp. 1609-1617. [Online]. 
  
Back to record